India's chemical sector recorded a 22% median revenue growth in Q1 FY2027, signaling an early recovery. However, return on capital remains restricted because significant new factory capacity is currently underutilized. Investors should monitor how quickly companies can ramp up production to align with their recent capital spending.
The Indian chemical industry is showing signs of a rebound, with most listed companies reporting revenue growth in the first quarter of fiscal year 2027. Data shows that 83% of firms in the sector achieved revenue growth, with a median increase of 22% compared to the previous year. While this indicates that demand is returning, investors should focus on the quality of this recovery, as profit margins and return on capital are not yet reflecting the full strength of this revenue expansion.
Aggregate sector margins reached 17.4% in the recent quarter, up from 15.5% in the prior period. However, analysts point out that these gains were largely supported by temporary factors, such as fluctuations in crude oil prices and shipping costs, rather than a pure increase in sales volume. As these short-term gains fade, companies will need to demonstrate that they can maintain profitability through consistent operational efficiency and higher production volumes.
The Capacity Utilization Bottleneck
The primary challenge preventing a sharper improvement in returns is an overhang of capacity built during previous expansion cycles. Many chemical companies invested heavily in new facilities between 2023 and 2025, expecting higher demand. Currently, these assets are not being fully used. Older, established specialty chemical plants are operating at 60% to 75% capacity, while newer, more expensive facilities are running at only 20% to 30% utilization. Because these new plants carry high overhead costs, their inability to operate near full scale acts as a drag on the company's overall return on capital.
Sector Risks and Market Outlook
While the industry is expected to grow from an estimated USD 36 billion in 2025 to USD 61 billion by 2030, the path to that goal involves significant risks. Companies continue to face pressure from Chinese manufacturers, who have been aggressive on pricing. Additionally, supply chain stability remains sensitive to geopolitical tensions in West Asia, which can impact freight and energy costs unexpectedly. The agrochemical sub-segment, in particular, is currently experiencing weaker demand, which adds to the uncertainty for companies with heavy exposure to that category.
To support the sector, the government's 'BHAVYA Rasayan' scheme was introduced in the Union Budget 2026-27, aiming to boost domestic manufacturing through new chemical parks. This policy support may provide a tailwind for long-term growth, but the immediate focus for investors remains on operational metrics. The next important step for the industry is to successfully ramp up production at newly commissioned plants. Investors may track quarterly utilization rates, raw material cost trends, and management commentary on demand for higher-value products to gauge how quickly these companies can turn their revenue growth into improved shareholder returns.